Agios Pharmaceuticals, Inc. (AGIO) Discusses Topline Results from RISE UP Phase 3 Trial of Mitapivat in Sickle Cell Disease - Slideshow (NASDAQ:AGIO) 2025-11-19
Agios Pharmaceuticals(US:AGIO) Seeking Alphaยท2025-11-19 15:24Group 1 - The article does not provide any relevant content regarding company or industry insights [1]